Parma, February 5th 2018 – Chiesi Group (Chiesi) is Top Employer Italy for the 10th year running and Top Employer Europe. This award is assigned to the companies that obtain this certificate in at least five EU Countries.
In addition to Italy, also the French, German, Poland, United Kingdom and Spain affiliates received this award. Moreover, for the third time in a row, also the American branch obtained the Top Employer USA award, while Chiesi Brazil received the Top Employers Brazil for the second time and The Russian and Turkish affiliates were awarded for their first time this year.
Top Employers Institute runs every year a comprehensive analysis of the company’s HR management policies. The certification is based on an extensive research that verifies that the required qualitative standards are met, basing the analysis on different criteria such as work environment, investments in training and development, remuneration policies, career opportunities, talent appreciation strategies and business culture.
“This important recognition has a special meaning this year: this is the 10th year running of Top Employer in Italy, and we also achieved the certification of 10 Chiesi subsidiaries”, commented Giorgio Cavalleri, Head of Chiesi Group People Development. “This proves that, in our Company culture, employees are considered the most important asset and are a strategic value for the business development”.
Among the most important Chiesi initiatives Top Employers Institute identifiedtraining activities for its employees, Talent Management programs, the internal climate survey and itsaction plans and welfare initiatives for employees .
“Our commitment for the future is to keep improving opportunities for our Colleagues, through specific and innovative training programs” said Giorgio Cavalleri “by supporting their growth path and strengthening the skills necessaryto support the Group’s growth”.
Based in Parma, Italy, Chiesi Farmaceutici is an international research-focused Healthcare Group, with over 80 years of experience and based in Parma and present in 26 countries. Chiesi researches, develops and markets innovative drugs in respiratory therapeutic areas and specialized medicine. In 2016, the company achieved a turnover of over 1.57 billion euros, an increase of 7.0% compared to 2015. The Parma Research Center, the laboratories of Paris (France), Cary (USA), Chippenham and Oxford (UK) and the R & D team of the Danish subsidiary Zymenex collaborate on the Group's pre-clinical, clinical and regimen programs. Chiesi employs over 5,000 people, 671 of which are dedicated to research and development activities and regulatory activities.